1 Immuno-Cell Therapy Market Overview 1.1 Product Overview and Scope of Immuno-Cell Therapy 1.2 Classification of Immuno-Cell Therapy by Type 1.2.1 Global Immuno-Cell Therapy Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Global Immuno-Cell Therapy Revenue Market Share by Type in 2019 1.2.3 Passive Immune (NK, LAK etc) 1.2.4 Active Immune 1.3 Global Immuno-Cell Therapy Market by Application 1.3.1 Overview: Global Immuno-Cell Therapy Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Oncology 1.3.3 Cardiovascular Disease (CVD) 1.3.4 Orthopedic 1.3.5 Wound Healing 1.3.6 Others 1.4 Global Immuno-Cell Therapy Market by Regions 1.4.1 Global Immuno-Cell Therapy Market Size by Regions: 2015 VS 2019 VS 2025 1.4.2 Global Market Size of Immuno-Cell Therapy (2015-2025) 1.4.3 North America (USA, Canada and Mexico) Immuno-Cell Therapy Status and Prospect (2015-2025) 1.4.4 Europe (Germany, France, UK, Russia and Italy) Immuno-Cell Therapy Status and Prospect (2015-2025) 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Immuno-Cell Therapy Status and Prospect (2015-2025) 1.4.6 South America (Brazil, Argentina, Colombia) Immuno-Cell Therapy Status and Prospect (2015-2025) 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Immuno-Cell Therapy Status and Prospect (2015-2025) 2 Company Profiles 2.1 MEDINET Co 2.1.1 MEDINET Co Details 2.1.2 MEDINET Co Major Business 2.1.3 MEDINET Co SWOT Analysis 2.1.4 MEDINET Co Product and Services 2.1.5 MEDINET Co Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.2 Gilead Sciences 2.2.1 Gilead Sciences Details 2.2.2 Gilead Sciences Major Business 2.2.3 Gilead Sciences SWOT Analysis 2.2.4 Gilead Sciences Product and Services 2.2.5 Gilead Sciences Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.3 Takeda 2.3.1 Takeda Details 2.3.2 Takeda Major Business 2.3.3 Takeda SWOT Analysis 2.3.4 Takeda Product and Services 2.3.5 Takeda Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.4 Erytech 2.4.1 Erytech Details 2.4.2 Erytech Major Business 2.4.3 Erytech SWOT Analysis 2.4.4 Erytech Product and Services 2.4.5 Erytech Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.5 Fate Therapeutics 2.5.1 Fate Therapeutics Details 2.5.2 Fate Therapeutics Major Business 2.5.3 Fate Therapeutics SWOT Analysis 2.5.4 Fate Therapeutics Product and Services 2.5.5 Fate Therapeutics Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.6 Seta Clinic Group 2.6.1 Seta Clinic Group Details 2.6.2 Seta Clinic Group Major Business 2.6.3 Seta Clinic Group Product and Services 2.6.4 Seta Clinic Group Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.7 Osiris 2.7.1 Osiris Details 2.7.2 Osiris Major Business 2.7.3 Osiris Product and Services 2.7.4 Osiris Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.8 Oxford BioTherapeutics 2.8.1 Oxford BioTherapeutics Details 2.8.2 Oxford BioTherapeutics Major Business 2.8.3 Oxford BioTherapeutics Product and Services 2.8.4 Oxford BioTherapeutics Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.9 SBI Holdings 2.9.1 SBI Holdings Details 2.9.2 SBI Holdings Major Business 2.9.3 SBI Holdings Product and Services 2.9.4 SBI Holdings Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.10 Novartis 2.10.1 Novartis Details 2.10.2 Novartis Major Business 2.10.3 Novartis Product and Services 2.10.4 Novartis Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.11 Golden Meditech 2.11.1 Golden Meditech Details 2.11.2 Golden Meditech Major Business 2.11.3 Golden Meditech Product and Services 2.11.4 Golden Meditech Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.12 Vericel Corporation 2.12.1 Vericel Corporation Details 2.12.2 Vericel Corporation Major Business 2.12.3 Vericel Corporation Product and Services 2.12.4 Vericel Corporation Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.13 Guanhao Biotech 2.13.1 Guanhao Biotech Details 2.13.2 Guanhao Biotech Major Business 2.13.3 Guanhao Biotech Product and Services 2.13.4 Guanhao Biotech Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.14 Beike Biotechnology 2.14.1 Beike Biotechnology Details 2.14.2 Beike Biotechnology Major Business 2.14.3 Beike Biotechnology Product and Services 2.14.4 Beike Biotechnology Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.15 Fujifilm Cellular Dynamics 2.15.1 Fujifilm Cellular Dynamics Details 2.15.2 Fujifilm Cellular Dynamics Major Business 2.15.3 Fujifilm Cellular Dynamics Product and Services 2.15.4 Fujifilm Cellular Dynamics Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.16 Beroni Group 2.16.1 Beroni Group Details 2.16.2 Beroni Group Major Business 2.16.3 Beroni Group Product and Services 2.16.4 Beroni Group Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 2.17 JCR Pharmaceuticals 2.17.1 JCR Pharmaceuticals Details 2.17.2 JCR Pharmaceuticals Major Business 2.17.3 JCR Pharmaceuticals Product and Services 2.17.4 JCR Pharmaceuticals Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2018-2019) 3 Market Competition, by Players 3.1 Global Immuno-Cell Therapy Revenue and Share by Players (2015-2020) 3.2 Market Concentration Rate 3.2.1 Top 5 Immuno-Cell Therapy Players Market Share 3.2.2 Top 10 Immuno-Cell Therapy Players Market Share 3.3 Market Competition Trend 4 Market Size by Regions 4.1 Global Immuno-Cell Therapy Revenue and Market Share by Regions 4.2 North America Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 4.3 Europe Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 4.4 Asia-Pacific Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 4.5 South America Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 4.6 Middle East & Africa Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 5 North America Immuno-Cell Therapy Revenue by Countries 5.1 North America Immuno-Cell Therapy Revenue by Countries (2015-2020) 5.2 USA Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 5.3 Canada Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 5.4 Mexico Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 6 Europe Immuno-Cell Therapy Revenue by Countries 6.1 Europe Immuno-Cell Therapy Revenue by Countries (2015-2020) 6.2 Germany Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 6.3 UK Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 6.4 France Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 6.5 Russia Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 6.6 Italy Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 7 Asia-Pacific Immuno-Cell Therapy Revenue by Countries 7.1 Asia-Pacific Immuno-Cell Therapy Revenue by Countries (2015-2020) 7.2 China Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 7.3 Japan Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 7.4 Korea Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 7.5 India Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 7.6 Southeast Asia Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 8 South America Immuno-Cell Therapy Revenue by Countries 8.1 South America Immuno-Cell Therapy Revenue by Countries (2015-2020) 8.2 Brazil Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 8.3 Argentina Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 9 Middle East & Africa Revenue Immuno-Cell Therapy by Countries 9.1 Middle East & Africa Immuno-Cell Therapy Revenue by Countries (2015-2020) 9.2 Saudi Arabia Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 9.3 UAE Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 9.4 Egypt Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 9.5 South Africa Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) 10 Market Size Segment by Type 10.1 Global Immuno-Cell Therapy Revenue and Market Share by Type (2015-2020) 10.2 Global Immuno-Cell Therapy Market Forecast by Type (2019-2024) 10.3 Passive Immune (NK, LAK etc) Revenue Growth Rate (2015-2025) 10.4 Active Immune Revenue Growth Rate (2015-2025) 11 Global Immuno-Cell Therapy Market Segment by Application 11.1 Global Immuno-Cell Therapy Revenue Market Share by Application (2015-2020) 11.2 Immuno-Cell Therapy Market Forecast by Application (2019-2024) 11.3 Oncology Revenue Growth (2015-2020) 11.4 Cardiovascular Disease (CVD) Revenue Growth (2015-2020) 11.5 Orthopedic Revenue Growth (2015-2020) 11.6 Wound Healing Revenue Growth (2015-2020) 11.7 Others Revenue Growth (2015-2020) 12 Global Immuno-Cell Therapy Market Size Forecast (2021-2025) 12.1 Global Immuno-Cell Therapy Market Size Forecast (2021-2025) 12.2 Global Immuno-Cell Therapy Market Forecast by Regions (2021-2025) 12.3 North America Immuno-Cell Therapy Revenue Market Forecast (2021-2025) 12.4 Europe Immuno-Cell Therapy Revenue Market Forecast (2021-2025) 12.5 Asia-Pacific Immuno-Cell Therapy Revenue Market Forecast (2021-2025) 12.6 South America Immuno-Cell Therapy Revenue Market Forecast (2021-2025) 12.7 Middle East & Africa Immuno-Cell Therapy Revenue Market Forecast (2021-2025) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source 14.3 Disclaimer 14.4 About US

List of Tables Table 1. Global Immuno-Cell Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Immuno-Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Immuno-Cell Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Global Market Immuno-Cell Therapy Revenue (Million USD) Comparison by Regions 2015-2025 Table 5. Global Immuno-Cell Therapy Market Size and Growth Estimation in Various Scenarios in 2020 Table 6. MEDINET Co Corporate Information, Location and Competitors Table 7. MEDINET Co Immuno-Cell Therapy Major Business Table 8. MEDINET Co Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 9. MEDINET Co SWOT Analysis Table 10. MEDINET Co Immuno-Cell Therapy Product and Solutions Table 11. MEDINET Co Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 12. Gilead Sciences Corporate Information, Location and Competitors Table 13. Gilead Sciences Immuno-Cell Therapy Major Business Table 14. Gilead Sciences Immuno-Cell Therapy Total Revenue (USD Million) (2018-2019) Table 15. Gilead Sciences SWOT Analysis Table 16. Gilead Sciences Immuno-Cell Therapy Product and Solutions Table 17. Gilead Sciences Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 18. Takeda Corporate Information, Location and Competitors Table 19. Takeda Immuno-Cell Therapy Major Business Table 20. Takeda Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 21. Takeda SWOT Analysis Table 22. Takeda Immuno-Cell Therapy Product and Solutions Table 23. Takeda Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 24. Erytech Corporate Information, Location and Competitors Table 25. Erytech Immuno-Cell Therapy Major Business Table 26. Erytech Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 27. Erytech SWOT Analysis Table 28. Erytech Immuno-Cell Therapy Product and Solutions Table 29. Erytech Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 30. Fate Therapeutics Corporate Information, Location and Competitors Table 31. Fate Therapeutics Immuno-Cell Therapy Major Business Table 32. Fate Therapeutics Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 33. Fate Therapeutics SWOT Analysis Table 34. Fate Therapeutics Immuno-Cell Therapy Product and Solutions Table 35. Fate Therapeutics Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 36. Seta Clinic Group Corporate Information, Location and Competitors Table 37. Seta Clinic Group Immuno-Cell Therapy Major Business Table 38. Seta Clinic Group Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 39. Seta Clinic Group SWOT Analysis Table 40. Seta Clinic Group Immuno-Cell Therapy Product and Solutions Table 41. Seta Clinic Group Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 42. Osiris Corporate Information, Location and Competitors Table 43. Osiris Immuno-Cell Therapy Major Business Table 44. Osiris Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 45. Osiris SWOT Analysis Table 46. Osiris Immuno-Cell Therapy Product and Solutions Table 47. Osiris Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 48. Oxford BioTherapeutics Corporate Information, Location and Competitors Table 49. Oxford BioTherapeutics Immuno-Cell Therapy Major Business Table 50. Oxford BioTherapeutics Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 51. Oxford BioTherapeutics SWOT Analysis Table 52. Oxford BioTherapeutics Immuno-Cell Therapy Product and Solutions Table 53. Oxford BioTherapeutics Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 54. SBI Holdings Corporate Information, Location and Competitors Table 55. SBI Holdings Immuno-Cell Therapy Major Business Table 56. SBI Holdings Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 57. SBI Holdings SWOT Analysis Table 58. SBI Holdings Immuno-Cell Therapy Product and Solutions Table 59. SBI Holdings Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 60. Novartis Corporate Information, Location and Competitors Table 61. Novartis Immuno-Cell Therapy Major Business Table 62. Novartis Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 63. Novartis SWOT Analysis Table 64. Novartis Immuno-Cell Therapy Product and Solutions Table 65. Novartis Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 66. Golden Meditech Corporate Information, Location and Competitors Table 67. Golden Meditech Immuno-Cell Therapy Major Business Table 68. Golden Meditech Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 69. Golden Meditech SWOT Analysis Table 70. Golden Meditech Immuno-Cell Therapy Product and Solutions Table 71. Golden Meditech Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 72. Vericel Corporation Corporate Information, Location and Competitors Table 73. Vericel Corporation Immuno-Cell Therapy Major Business Table 74. Vericel Corporation Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 75. Vericel Corporation SWOT Analysis Table 76. Vericel Corporation Immuno-Cell Therapy Product and Solutions Table 77. Vericel Corporation Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 78. Guanhao Biotech Corporate Information, Location and Competitors Table 79. Guanhao Biotech Immuno-Cell Therapy Major Business Table 80. Guanhao Biotech Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 81. Guanhao Biotech SWOT Analysis Table 82. Guanhao Biotech Immuno-Cell Therapy Product and Solutions Table 83. Guanhao Biotech Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 84. Beike Biotechnology Corporate Information, Location and Competitors Table 85. Beike Biotechnology Immuno-Cell Therapy Major Business Table 86. Beike Biotechnology Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 87. Beike Biotechnology SWOT Analysis Table 88. Beike Biotechnology Immuno-Cell Therapy Product and Solutions Table 89. Beike Biotechnology Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 90. Fujifilm Cellular Dynamics Corporate Information, Location and Competitors Table 91. Fujifilm Cellular Dynamics Immuno-Cell Therapy Major Business Table 92. Fujifilm Cellular Dynamics Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 93. Fujifilm Cellular Dynamics SWOT Analysis Table 94. Fujifilm Cellular Dynamics Immuno-Cell Therapy Product and Solutions Table 95. Fujifilm Cellular Dynamics Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 96. Beroni Group Corporate Information, Location and Competitors Table 97. Beroni Group Immuno-Cell Therapy Major Business Table 98. Beroni Group Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 99. Beroni Group SWOT Analysis Table 100. Beroni Group Immuno-Cell Therapy Product and Solutions Table 101. Beroni Group Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 102. JCR Pharmaceuticals Corporate Information, Location and Competitors Table 103. JCR Pharmaceuticals Immuno-Cell Therapy Major Business Table 104. JCR Pharmaceuticals Immuno-Cell Therapy Total Revenue (USD Million) (2017-2018) Table 105. JCR Pharmaceuticals SWOT Analysis Table 106. JCR Pharmaceuticals Immuno-Cell Therapy Product and Solutions Table 107. JCR Pharmaceuticals Immuno-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 108. Global Immuno-Cell Therapy Revenue (Million USD) by Players (2015-2020) Table 109. Global Immuno-Cell Therapy Revenue Share by Players (2015-2020) Table 110. Global Immuno-Cell Therapy Revenue (Million USD) by Regions (2015-2020) Table 111. Global Immuno-Cell Therapy Revenue Market Share by Regions (2015-2020) Table 112. North America Immuno-Cell Therapy Revenue by Countries (2015-2020) Table 113. North America Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020) Table 114. Europe Immuno-Cell Therapy Revenue (Million USD) by Countries (2015-2020) Table 115. Asia-Pacific Immuno-Cell Therapy Revenue (Million USD) by Countries (2015-2020) Table 116. South America Immuno-Cell Therapy Revenue by Countries (2015-2020) Table 117. South America Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020) Table 118. Middle East and Africa Immuno-Cell Therapy Revenue (Million USD) by Countries (2015-2020) Table 119. Middle East and Africa Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020) Table 120. Global Immuno-Cell Therapy Revenue (Million USD) by Type (2015-2020) Table 121. Global Immuno-Cell Therapy Revenue Share by Type (2015-2020) Table 122. Global Immuno-Cell Therapy Revenue Forecast by Type (2021-2025) Table 123. Global Immuno-Cell Therapy Revenue by Application (2015-2020) Table 124. Global Immuno-Cell Therapy Revenue Share by Application (2015-2020) Table 125. Global Immuno-Cell Therapy Revenue Forecast by Application (2021-2025) Table 126. Global Immuno-Cell Therapy Revenue (Million USD) Forecast by Regions (2021-2025) List of Figures Figure 1. Immuno-Cell Therapy Picture Figure 2. Global Immuno-Cell Therapy Revenue Market Share by Type in 2019 Figure 3. Passive Immune (NK, LAK etc) Picture Figure 4. Active Immune Picture Figure 5. Immuno-Cell Therapy Revenue Market Share by Application in 2019 Figure 6. Oncology Picture Figure 7. Cardiovascular Disease (CVD) Picture Figure 8. Orthopedic Picture Figure 9. Wound Healing Picture Figure 10. Others Picture Figure 11. Global Immuno-Cell Therapy Revenue (USD Million) and Growth Rate (2015-2025) Figure 12. North America Immuno-Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025) Figure 13. Europe Immuno-Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025) Figure 14. Asia-Pacific Immuno-Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025) Figure 15. South America Immuno-Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025) Figure 16. Middle East and Africa Immuno-Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025) Figure 17. Global Immuno-Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025) Figure 18. Global Immuno-Cell Therapy Revenue Share by Players in 2019 Figure 19. Global Top 5 Players Immuno-Cell Therapy Revenue Market Share in 2019 Figure 20. Global Top 10 Players Immuno-Cell Therapy Revenue Market Share in 2019 Figure 21. Key Players Market Share Trend Figure 22. Global Immuno-Cell Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020) Figure 23. Global Immuno-Cell Therapy Revenue Market Share by Regions (2015-2020) Figure 24. Global Immuno-Cell Therapy Revenue Market Share by Regions in 2018 Figure 25. North America Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 26. Europe Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 27. Asia-Pacific Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 28. South America Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 29. Middle East and Africa Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 30. North America Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020) Figure 31. North America Immuno-Cell Therapy Revenue Market Share by Countries in 2019 Figure 32. USA Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 33. Canada Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 34. Mexico Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 35. Europe Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020) Figure 36. Europe Immuno-Cell Therapy Revenue Market Share by Countries in 2019 Figure 37. Germany Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 38. UK Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 39. France Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 40. Russia Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 41. Italy Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 42. Asia-Pacific Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020) Figure 43. Asia-Pacific Immuno-Cell Therapy Revenue Market Share by Countries in 2019 Figure 44. China Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 45. Japan Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 46. Korea Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 47. India Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 48. Southeast Asia Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 49. South America Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020) Figure 50. South America Immuno-Cell Therapy Revenue Market Share by Countries in 2019 Figure 51. Brazil Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 52. Argentina Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 53. Middle East and Africa Immuno-Cell Therapy Revenue Market Share by Countries (2015-2020) Figure 54. Middle East and Africa Immuno-Cell Therapy Revenue Market Share by Countries in 2019 Figure 55. Saudi Arabia Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 56. UAE Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 57. Egypt Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 58. South Africa Immuno-Cell Therapy Revenue and Growth Rate (2015-2020) Figure 59. Global Immuno-Cell Therapy Revenue Share by Type (2015-2020) Figure 60. Global Immuno-Cell Therapy Revenue Share by Type in 2019 Figure 61. Global Immuno-Cell Therapy Market Share Forecast by Type (2021-2025) Figure 62. Global Passive Immune (NK, LAK etc) Revenue Growth Rate (2015-2020) Figure 63. Global Active Immune Revenue Growth Rate (2015-2020) Figure 64. Global Immuno-Cell Therapy Revenue Share by Application (2015-2020) Figure 65. Global Immuno-Cell Therapy Revenue Share by Application in 2019 Figure 66. Global Immuno-Cell Therapy Market Share Forecast by Application (2021-2025) Figure 67. Global Oncology Revenue Growth Rate (2015-2020) Figure 68. Global Cardiovascular Disease (CVD) Revenue Growth Rate (2015-2020) Figure 69. Global Orthopedic Revenue Growth Rate (2015-2020) Figure 70. Global Wound Healing Revenue Growth Rate (2015-2020) Figure 71. Global Others Revenue Growth Rate (2015-2020) Figure 72. Global Immuno-Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025) Figure 73. Global Immuno-Cell Therapy Revenue (Million USD) Forecast by Regions (2021-2025) Figure 74. Global Immuno-Cell Therapy Revenue Market Share Forecast by Regions (2021-2025) Figure 75. North America Immuno-Cell Therapy Revenue Market Forecast (2021-2025) Figure 76. Europe Immuno-Cell Therapy Revenue Market Forecast (2021-2025) Figure 77. Asia-Pacific Immuno-Cell Therapy Revenue Market Forecast (2021-2025) Figure 78. South America Immuno-Cell Therapy Revenue Market Forecast (2021-2025) Figure 79. Middle East and Africa Immuno-Cell Therapy Revenue Market Forecast (2021-2025) Figure 80. Sales Channel: Direct Channel vs Indirect Channel

MEDINET Co Gilead Sciences Takeda Erytech Fate Therapeutics Seta Clinic Group Osiris Oxford BioTherapeutics SBI Holdings Novartis Golden Meditech Vericel Corporation Guanhao Biotech Beike Biotechnology Fujifilm Cellular Dynamics Beroni Group JCR Pharmaceuticals